Evoluation of seismic isolation systems in terms of cost–benefit analysis
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
In this research, considering the loss of life and property caused by the earthquakes in the past, the situation of Turkey's geography with high seismic fault lines is also evaluated in terms of cost-benefit of seismic isolation systems that absorb seismic energy in buildings in order to minimize or completely neutralize the damaging effects of earthquake forces. It was tried to ensure that the necessity and awareness of its use were evaluated by evaluating it. After the preliminary evaluation of the data obtained from the questionnaire study with the determined sample group, statistical analysis was performed with the SPSS (Statistical Package for the Social Sciences) computer program. In the findings, it has been determined that seismic isolation systems provide high benefits against earthquake risk and that they should be used.
Author
Mete Ürkmezyel
Institution

Maltepe University
Yapı Deprem Mühendisliği Bilim Dalı
How to Cite
Mete Ürkmezyel (Master Thesis). Evoluation of seismic isolation systems in terms of cost–benefit analysis, 2023, Maltepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Maltepe University
- Effective cash management in businesses and cash flow focused approach to financial failure predict: A research in Borsa İstanbul(2023)
- Digitalization in health communication: SABİM in the context of public health communications(2023)
- The effect of glutathione on sperm dna fragmentation in rat models of bleomycin etoposide cis-platin treatment(2023)
- Social policy practies in the context of fichting poverty,the case of Cizre, Şırnak, 2021(2023)
- Expression of sirtuin (SİRT) and apoptosis genes in granulosa cells of offspring of leptin-administered mice(2023)
- Investigation of sperm vitality and mortility in male pup of pregnant mice receiving subcutaneous leptin(2023)